Please login to the form below

Not currently logged in
Email:
Password:

Aesica creates commercial MD role

Appoints Catalent’s Ian Muir to new position

Aesica has named Ian Muir as the company's first commercial managing director, effective February 24.

The contract development and manufacturing (CDMO) firm Aesica said the creation of the role reflects the company's decision to focus on 'core commercial activities'.

Muir's responsibilities will cover manufacture of active pharmaceutical ingredients, formulation development and formulated products, while he will also lead the expansion of the business into new markets, such as China and Japan.

He joins from the CDMO Catalent where he was responsible for the global provision of contract development and manufacturing services for oral dose forms.

Muir's previous experience also includes commercial responsibilities in the US, Australia and Japan.

Aesica's CEO Robert Hardy said: “Ian brings strong commercial business knowledge and has proven experience of delivering growth and will play a pivotal role in driving further business growth for Aesica across API, formulation development and formulated products.”

5th February 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics